Clinical Trial Update: Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex [NA]

View source ↗

Summary

Clinical trial update investigating treating pemphigus with rituximab 1000 mg given twice and assessing immune status using the Cylex test.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Rabin Medical Center | Conditions: Pemphigus | NA | Status: UNKNOWN